Arbutus Biopharma (ABUS) PT Lowered to $8 at H.C. Wainwright, Following Earnings, Recent Dilution
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $8.00 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
